The power of pathway-based polygenic risk scores
Shing Wan Choi(Icahn School of Medicine at Mount Sinai), Paul F. O’Reilly(Icahn School of Medicine at Mount Sinai), Judit García‐González(Icahn School of Medicine at Mount Sinai), Hei Man Wu(Icahn School of Medicine at Mount Sinai), Jessica Johnson(University of North Carolina at Chapel Hill), Yunfeng Ruan(Broad Institute), Clive Hoggart(Icahn School of Medicine at Mount Sinai)
Cited by 16
Related Papers
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
|Nature|2011|2.1k
De novo mutations in schizophrenia implicate synaptic networks
|Nature|2014|1.7k
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
|The Lancet|2010|1.5k
Gene expression elucidates functional impact of polygenic risk for schizophrenia
|Nature Neuroscience|2016|1.2k
Identification of seven loci affecting mean telomere length and their association with disease
|Nature Genetics|2013|970